Funding for this research was provided by:
National Institute on Drug Abuse (U01DA036221)
Received: 11 May 2022
Accepted: 9 November 2022
First Online: 20 December 2022
: The study obtained a Certificate of Confidentiality from the National Institutes of Health. The study was conducted under the supervision of Chestnut Health Systems’ Institutional Review Board (IRB) for the Protection of Human Subjects (IRB Research Study No. 1134–0419). Participants gave written consent; their participation in the study was voluntary and they could choose not to answer any question without consequences.
: Not applicable as no individual respondents identified.
: The authors declare that they have no competing interests.